[Federal Register: September 9, 2003 (Volume 68, Number 174)]
[Notices]
[Page 53180]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09se03-100]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer
Liaison Group.
    Date: September 24, 2003.
    Time: 8 a.m. to 5 p.m.
    Agenda: Open; Future of DCLG Process; Results of Advocacy
Survey; Recommendations for Future of DCLG; Role on Behalf of
Advocacy Community; Advocates on Other NCI Advisory Committees;
Priority Issues; President's Cancer Panel Model; Function Regarding
NCI Priorities; Role of Consumer in Research and Related Activities
Program; Membership; Communication/Involvement with Advocacy
Community; Summary & Next Steps.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD
20852.
    Contact Person: Nancy Caliman, Executive Secretary, Office of
Liaison Activities, National Institutes of Health, National Cancer
Institute, 6116 Executive Boulevard, Suite 220, MSC 8324, Bethesda,
MD 20892, (301) 496-0307, calimann@mail.nih.gov.    Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda
and any additional information for the meeting will be posted when
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support, 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)

    Dated: August 26, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-22816 Filed 9-8-03; 8:45 am]

BILLING CODE 4140-01-M